JATT Acquisition (NYSE:JATT) Stock Price Up 0.7% – What’s Next?

JATT Acquisition Corp (NYSE:JATT)’s share price traded up 0.7% during trading on Wednesday. The company traded as high as $10.37 and last traded at $10.32. 5,566 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 22,263 shares. The stock had previously closed at $10.25.

JATT Acquisition Stock Performance

The company has a 50 day simple moving average of $11.31 and a 200 day simple moving average of $9.56.

Institutional Trading of JATT Acquisition

A hedge fund recently bought a new stake in JATT Acquisition stock. Spruce Street Capital LP purchased a new stake in JATT Acquisition Corp (NYSE:JATT) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 160,000 shares of the company’s stock, valued at approximately $1,817,600. Spruce Street Capital LP owned approximately 1.99% of JATT Acquisition at the end of the most recent reporting period. Institutional investors and hedge funds own 47.97% of the company’s stock.

JATT Acquisition Company Profile

JATT Acquisition Corp. was a special purpose acquisition company (SPAC) formed to identify and combine with a business in the healthcare, biotechnology, or related life sciences sectors. As a SPAC, it did not operate a commercial business or offer products and services of its own before completing a business combination.

JATT announced a proposed merger with Zura Bio Limited, a biotechnology company developing therapies for immune-mediated diseases. The transaction was completed in 2023, resulting in Zura Bio becoming a publicly traded company under the ticker symbol ZURA.

Following the completion of the merger, JATT Acquisition Corp.